Growing knowledge about the aggressiveness and metastatic potential of TFE3-rearranged RCC only serves to emphasize the need for reliable, affordable and accessible markers that enable pathologists to render timely diagnoses. The gene discussed is TFE3; the disease is renal cell carcinoma.